Fig. 4From: Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusionBRAF and phospho-FGFR1 immunostaining. a Immunohistochemistry on section from case 5 showing tumor cells stongly labeled in the two components with an antibody against BRAF V600E. b Immunohistochemistry from case 1 showing the tumor immunoreactive with an antibody against phospho-FGFR1. Magnification x200Back to article page